Administration of gonadotrophin-releasing hormone (GnRH) agonist in a 29 year old woman with infertility due to ovulatory dysfunction resulted in the development of several ovarian cysts. After human chorionic gonadotrophin (HCG) was injected, the cysts were aspirated and one mature oocyte was retrieved. Intracytoplasmic sperm injection (ICSI) was performed and the resulting embryo was transferred. A singleton pregnancy was obtained and a healthy baby was born at 36 weeks of gestation. Because GnRH agonist-derived cysts may contain oocytes, we suggest that when the growth of cysts is accompanied by high concentrations of oestradiol, the administration of HCG may be useful to achieve oocyte maturation and advance IVF treatment.
Introduction
stimulating hormone (TSH) were normal. Polycystic ovaries were indicated by sonography. The use of gonadotrophin releasing hormone (GnRH) agonist Three years previously, an IVF treatment (14 oocytes in IVF cycles is associated with an estimated 5% incidence of retrieved, 50% fertilization) combined with zygote intraovarian cysts (Jenkins, 1996; Mehta and Anand Kumar, 2000) .
Fallopian transfer had resulted in a pregnancy and the birth of The risk of cyst formation increases in women with ovulatory a healthy boy weighing 2970 g. During the last 2 years, two dysfunction (Feldberg et al., 1989; Lockwood et al., 1995;  IVF cycles were attempted (23 and 18 oocytes were achieved Jenkins, 1996; Ellenbogen et al., 1997; Mehta and Anand with 48% and 39% fertilization rates respectively), but the Kumar, 2000), and when GnRH agonist treatment is initiated woman did not conceive. On day 21 of the menstrual cycle at the follicular rather than the luteal phase of the menstrual preceding her treatment cycle, oestradiol and progesterone cycle (Lockwood et al., 1995; Mehta and Anand Kumar, 2000) .
concentrations were 200 pmol/l and 1.9 nmol/l respectively. The formation of ovarian cysts following pituitary downTransvaginal sonography revealed small follicles and GnRH regulation is considered detrimental. Thus, in many cases IVF agonist (Decapeptyl CR 3.75 mg; Ferring, Kiel, Germany) cycles are cancelled or cysts are aspirated to discontinue their was initiated. Eleven days later, oestradiol and progesterone functional activity (Feldberg et al., 1988; Rizk et al., 1990;  concentrations were 5276 pmol/l and 3.0 nmol/l, respec- Silverberg et al., 1990; Jenkins et al., 1992; Ellenbogen tively. Sonography revealed seven follicle-cysts (2.0-2.4 cm et al., 1997).
in diameter) and the endometrial thickness was 6 mm. The In this case report we present a woman with impaired woman expressed her wish to have the cysts aspirated in order ovarian function, who developed an oocyte-containing cyst to advance her treatment. She agreed to our suggestion to upon GnRH agonist administration. Following the use of HCG attempt HCG administration in case the follicles contained and ICSI, a successful pregnancy was established.
oocytes. HCG (10000 IU; Chorigon, Teva, Kfar Savah, Israel) was administered and 36 h later the follicle-cysts were Case Report aspirated. The aspirates were examined and a single oocyte A 29-year-old woman presented with 5 years of primary was retrieved. Because the husband had a low concentration infertility and 2 years of secondary infertility due to of motile sperm (a total of 0.8ϫ10 6 spermatozoa with poor ovulatory dysfunction (menstrual bleeding every 30-90 motility) and because we were concerned that IVF insemination days) and husband's oligoasthenospermia. The patient's LH of a single oocyte might result in failed fertilization, ICSI was and FSH concentrations were 15 IU/l and 10.4 IU/l respectively performed. We suggested to our patient the option of freezing the single embryo for a later transfer along with other fresh (upper limits of normal levels). Prolactin, thyroxine and thyroid or frozen embryos but the women preferred to complete the enabled and embryo implantation was successful. The inhibitory effect of GnRH agonist on corpus luteum activity was treatment. After~48 h a 4-cell embryo was transferred into the uterus. On the day of embryo transfer endometrial thickness overcome by progesterone administration. The procedure presented in this report may be considered was 9 mm and serum oestradiol and progesterone concentrations were 1402 pmol/l and Ͼ130 nmol/l respectively. Daily as a treatment option when follicle-cysts to be aspirated are accompanied by a significant rise in circulating oestradiol injections of 100 mg i.m. progesterone (Geston; Pains and Byrne, Surrey, UK) were provided for luteal phase support.
concentrations. However, the practice is suboptimal because the oocyte yield might be low, thus affecting the final outcome The woman conceived and a healthy baby boy weighing 2800 g was born at 36 weeks of gestation.
of the treatment. Being aware of the large resources required to complete an IVF cycle, we suggest that this procedure should be applied in carefully selected cases and combined Discussion with the option of embryo cryopreservation. The use of GnRH agonist has been associated with an increased incidence of functional ovarian cysts. The mechanisms of cyst gonadotrophic amenorrhoea (Check et al., 1988) . Because our Ron El, R., Raziel, A., Herman, A. et al. (1989) with elevated endogenous gonadotrophins. J. In Vitro Fertil. Embryo Trans., 7, [153] [154] [155] [156] It seems that the GnRH agonist did not impair oocyte quality and endometrial receptivity because normal fertilization was
